In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject

被引:92
|
作者
Tsibris, Athe M. N. [1 ,2 ]
Sagar, Manish [2 ,3 ]
Gulick, Roy M. [4 ]
Su, Zhaohui [5 ]
Hughes, Michael [5 ]
Greaves, Wayne [6 ]
Subramanian, Mani
Flexner, Charles [7 ]
Giguel, Francoise [1 ]
Leopold, Kay E. [8 ]
Coakley, Eoin [9 ]
Kuritzkes, Daniel R. [2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[5] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[6] Schering Plough Res Inst, Kenilworth, NJ USA
[7] Johns Hopkins Univ, Baltimore, MD USA
[8] Harvard Univ, Cambridge, MA 02138 USA
[9] Monogram Biosci, San Francisco, CA USA
关键词
D O I
10.1128/JVI.00444-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Little is known about the in vivo development of resistance to human immunodeficiency virus type 1 (HIV-1) CCR5 antagonists. We studied 29 subjects with virologic failure from a phase IIb study of the CCR5 antagonist vicriviroc (VCV) and identified one individual with HIV-1 subtype C who developed VCV resistance. Studies with chimeric envelopes demonstrated that changes within the V3 loop were sufficient to confer VCV resistance. Resistant virus showed VCV-enhanced replication, cross-resistance to another CCR5 antagonist, TAK779, and increased sensitivity to aminooxypentane-RANTES and the CCR5 monoclonal antibody HGS004. Pretreatment V3 loop sequences reemerged following VCV discontinuation, implying that VCV resistance has associated fitness costs.
引用
收藏
页码:8210 / 8214
页数:5
相关论文
共 50 条
  • [31] Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy
    Rodés, B
    Holguín, A
    Soriano, V
    Dourana, M
    Mansinho, K
    Antunes, F
    González-Lahoz, J
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (04) : 1370 - 1374
  • [32] Polymorphisms in Nef associated with different clinical outcomes in HIV type 1 subtype C-infected children
    Walker, Polly R.
    Ketunuti, Melissa
    Choge, Isaac A.
    Meyers, Tammy
    Gray, Glenda
    Holmes, Edward C.
    Morris, Lynn
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (02) : 204 - 215
  • [33] In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus
    Jamieson, BD
    Zack, JA
    JOURNAL OF VIROLOGY, 1998, 72 (08) : 6520 - 6526
  • [34] Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C
    Mutsvangwa, J.
    Beck, I. A.
    Gwanzura, L.
    Manhanzva, M. T.
    Stranix-Chibanda, L.
    Chipato, T.
    Frenkel, L. M.
    JOURNAL OF VIROLOGICAL METHODS, 2014, 210 : 36 - 39
  • [35] In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: Mutations, kinetics, and frequencies
    Jacobsen, H
    Hanggi, M
    Ott, M
    Duncan, IB
    Owen, S
    Andreoni, M
    Vella, S
    Mous, J
    JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06): : 1379 - 1387
  • [36] In vivo cytolysis and fusion of human immunodeficiency virus type 1-infected lymphocytes in lymphoid tissue
    Orenstein, JM
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01): : 338 - 342
  • [37] Distribution of human immunodeficiency virus type 1 subtypes in the State of Amazonas, Brazil, and subtype C identification
    Cunha, L. K. H.
    Kashima, S.
    Amarante, M. F. C.
    Haddad, R.
    Rodrigues, E. S.
    Silva, K. L. T.
    Lima, T. A.
    Castro, D. B.
    Brito, F. C.
    Almeida, E. G.
    Covas, D. T.
    Malheiro, A.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2012, 45 (02) : 104 - 112
  • [38] Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients
    Björndal, Å
    Sönnerborg, A
    Tscherning, C
    Albert, J
    Fenyö, EM
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (07) : 647 - 653
  • [39] Full-length genome analysis of human immunodeficiency virus type 1 subtype C in Brazil
    Sanabani, S
    Neto, WK
    De Sa, DJ
    Diaz, RS
    Munerato, P
    Janini, LM
    Sabino, EC
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (02) : 171 - 176
  • [40] Delayed tooth emergence in children infected with human immunodeficiency virus
    Psoter, Walter J.
    Nelson, Evelyn M.
    Psoter, Kevin J.
    Dearing, Bianca A.
    Katz, Ralph V.
    Catalanotto, Frank
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2016, 122 (04): : 442 - 447